Abiopharma

Coherent’s Chief Technology Officer Named Recipient of the Prestigious 2025 Dr. Lisa Su Woman of Innovation Award

Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)

New Form 6-K - Nyxoah SA Filed: 2025-09-08 AccNo: 0001104659-25-088240 Size: 39 KB

Kerr Douglas 🔴 sold 4.4K shares of Dyne Therapeutics, Inc. (DYN) at $13.41 Transaction Date: Sep 04, 2025 | Filing ID: 113538

New Form 8-K - BICYCLE THERAPEUTICS PLC Filed: 2025-09-08 AccNo: 0001104659-25-088238 Size: 262 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

MindMed Announces New Employee Inducement Grants

New Form 144 - CORE MOLDING TECHNOLOGIES INC Filed: 2025-09-08 AccNo: 0001949846-25-000454 Size: 5 KB

New Form 6-K - SciSparc Ltd. Filed: 2025-09-08 AccNo: 0001213900-25-085510 Size: 11 KB

Ionis to host investors and analysts for Innovation Day 2025

Abivax Presents First Half 2025 Financial Results

Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering

New Form 8-K - BioSig Technologies, Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026853 Size: 467 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Notification from CorMedix Inc.

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

New Form 144 - Twist Bioscience Corp Filed: 2025-09-08 AccNo: 0001959173-25-005838 Size: 7 KB